Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Funny you mention that. It’s exactly how MABs got approved.
Begging the question. Clearing the “hair loss”, does that really treat AD?
What’s the title?
Wait….
You talking about the same FDA that went against all of their advisors not too long ago and approved a therapy that failed in trials? Only to be data mined later to squeeze “ahh, there it is” BS?
Seem worried Kund.
It’d be fun to see the updated view when that peer review finally does get released.
I’m sure the majority of the board could care less what your doom and gloom thoughts are.
There’s still the entire week for them to PR something.
Heck, they may even PR something juicy with “further details” at “name the conference or date”
Just remember….Anything they DO present, the AF of the world will get it before it’s public thanks to his “reporter” status.
O.T. already approved huh.
There HAS to be something better to do than monitor message boards on a Friday night
Traded I could understand. All bought…..meh
There’s a high degree of probability that post won’t age well.
I wouldn’t be surprised, there was a small convo about Amazon being able to distribute and next thing you know, Missling mentions it.
They’d have to no matter what for pediatric Rett.
Pediatric is a totally different adult trials.
Case closed.
You and I have a different opinion on who the media is.
Whom exactly was the “media”?
I’ll entertain Kunds griping about pill labeling for a second.
Comparing recently approved vs not approved AD therapy.
Let’s label everything that we know of as required, for said therapy, with their ticker.
Let’s forget about cost difference for the insurance companies.
Let’s forget about the total opposite side of the spectrum side effects each had.
Let’s even forget about total time wasted, for patients, to be on each therapy and required visits.
That pill is a powerful message for those who know.
When Anavex finally reveals their cards, I’d not be surprised at all that it’ll beat MABs in a line for line comparison.
Que the peer review
Come on guy. It’s a nothingburger.
Can’t wait for the reaction when A-273 is approved and the pill looks completely different.
Oh no……I’ve been duped.
Because Anavex did get their therapy approved, knowing what the marketing name will be as well…..
Everyone is making a big deal from something so minute as 4 letters on a pill graphic……?
Inhale……breathe out…..everything is ok
Monday we go up, we go down, or maybe even be a flat day.
The world moves on from slide…what was that slide again. ….
Must be doing something right for you to still be posting nonsense
Why not? Those 3.50-3.80 shares are up 30% already. Much faster than traditional ways.
It’s a no brainer at these low prices.
To each their own.
Missling already said that they’ll start another pediatric trial using lessons learned.
Understood that.
Then again, that would mean AD submission on hold as well for FDA.
I would guess the voucher was out of the question once the pediatric trial missed.
My question is this.
With pediatric Rett having to go another trial, will the adult be submitted for approval or will Anavex wait for the pediatric trial to start, complete, and data crunched AGAIN if it is successful.
Or, will the FDA be willing to roll the pediatric trial in knowing what type of data is needed before it even became fully enrolled.
Can’t imagine waiting for pediatric when adults could use some help as well.
Yea, no links and just opinion is truly helpful. At least George, even though it’s YEARS old, attaches links to his posts 1/4 of the time.
Information that helps an investor to make an informed decision is A LOT better than what this board has descended to the last year or two.
That is a FACT
Some need to get off of their high horse and stop pretending they know it all.
Cause if they did, they wouldn’t be wasting their time on the hub
Obviously, if tutes end up with more than 39.2% on the next report, that’ll be true.
Nothing like demoralizing retail with the low SP while tutes happily take it off of retail hands.
Why not? Others have been claiming plaque removal IS it the last few decades even now, with proof that a critical analysis that supports that idea was flawed.
Funny how that works….science being a hypothesis, and even with the evidence of the trail of failed trials, they STILL believe in said hypothesis.
Maybe 100% is not needed.
All that is needed is for the general public to understand that plaque clearing is a failure. Sigmar articles are slowly starting to gain traction.
Peer review can’t come soon enough.
Sometimes, there’s that one stock that if invested early enough….that’s all she wrote.
It’s rare, but does occasionally happen when least expected.
This proves this poster has no desire to tell truth.
Adult was successful, pediatric missed the mark.
The article clearly doesn’t say what it was talking about.
THAT would be something. To have a clear better outcome than the SOC, even with the recent trash that just got approved, which in no way shape or form can even compare to the SOC just on safety alone.
Yet the tutes seem to continue accumulating. Let’s see if it’ll be even higher next quarter or less.
That’s the name of the game right?
Deter any potential new investors from purchasing.
Suggesting it’s a bad stock, yet it’ll 100% hit $8 before $1.
Making it an easy double and beyond
It’s so easy to block someone you know. Then you can always have a nice week.
Damn dude. Calm down, stock only went up $.50. Should save the best ramblings for bigger Green Days
Yep. Discourage eyes on the ticker. Nothing to see here…..And in case you look tomorrow, I’ll flood the board tomorrow as well.
Times slowly running out for that narrative.
39.x percent doesn’t seem to think so.
Good thing the Dr. doesn’t say he’s about to drop a deuce.
People literally take every single thing the guy says out of proportion.
He said Amazon could distribute.
He said Blarcamesine is like an iceburg.
He said undisclosed indication for a WHILE now.
Yet, a million pages sticks.
Welp, the “clown” just got voted as ceo for another year. So I expect nothing but another year of nonsense from you for at least the next year as well.
Cheers
LOL too funny Kund. Really, what would it be if it were SAVA……?
There you have it. Take the ticker out and watch the vast difference
Just curious as it was a reason I stopped loaning a few years ago. Along with a fine print that it’s not a guarantee that you’ll get the shares back. Could just be paid back the $ equivalent at the time of loan.